Medical and Pharmaceutical Allarity Therapeutics doses first patients in VA-funded small cell lung cancer trial The drug being examined, stenoparib, is also showing promise in ovarian cancer treatment Rowan Dunne4 days ago
Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan Dunne5 days ago
Medical and Pharmaceutical GRAIL plunges hard after ‘Galleri’ multi-cancer test fails to meet primary endpoint The slide comes in tandem with financial results that beat expectations Rowan DunneFebruary 20, 2026
Medical and Pharmaceutical Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test The ctDNA blood draw is known for its ultrasensitive detection capabilities Rowan DunneFebruary 10, 2026
Medical and Pharmaceutical European Lung Cancer Screening Alliance to launch this month News of the upcoming debut came the day before World Cancer Day, Feb. 4 Rowan DunneFebruary 4, 2026
Medical and Pharmaceutical Chinese authorities approve new lung cancer screening blood draw It has demonstrated exceptional early-stage detection capabilities Rowan DunneFebruary 3, 2026
Medical and Pharmaceutical Philadelphia hospital initiates research partnership with canine cancer detection specialist ‘SpotitEarly’ Fox Chase Cancer Center will be leading a multi-year clinical study assessing SpotitEarly's lung cancer test Rowan DunneFebruary 2, 2026
Medical and Pharmaceutical ENvue Medical skyrockets on reusable feeding tube syringe distribution deal Shares rose by more than 115% on the back of the news Rowan DunneJanuary 29, 2026
Medical and Pharmaceutical NHS lung cancer screening pilot combines power of AI software and robotic bronchoscopy Optellum's AI detects nodules and Intuitive Surgical's device performs a precision biopsy Rowan DunneJanuary 28, 2026
Medical and Pharmaceutical Leading oncology organizations condemn ‘misinformation’ about lung cancer screening dangers One widely cited study was apparently relying on data from Japanese atomic bomb survivors Rowan DunneJanuary 26, 2026